Skip to content

Vertex Pharmaceuticals Inc.

American pharmaceutical company

VRTX Nasdaq SEC CIK 875320

Follow Vertex Pharmaceuticals Weekly email: filings, results, news

News

9 stories filed under Vertex Pharmaceuticals, grouped into ongoing threads

Biotech

Thread · 3 stories

How Is Vertex Pharmaceuticals' Stock Performance Compared to Other Biotech Stocks?

Markets 22 d ago also on VERX

Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More

Markets 41 d ago also on VERX

Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?

Markets 48 d ago also on VERX

More coverage

Vertex Pharmaceuticals: Solid Growth But Valuation Still Requires Flawless Execution

Markets 15 d ago also on VERX

Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project

Markets 37 d ago

Vortex Energy Engages Market Maker

Markets 38 d ago

Can AbCellera Biologics (ABCL)’s Vertex Pharmaceuticals Incorporated (VRTX) Deal Turn its TCE Platform Into a Breakthrough?

Markets 41 d ago also on VERX ABCL

Vertex Pharmaceuticals: I Was Wrong About Its Near-Term Prospects (Rating Upgrade)

Markets 41 d ago also on VERX

Why is Vertex Pharmaceuticals stock surging today?

Markets 45 d ago 2 sources also on VERX

Next results

NOV3

Q2 2026 results

Tuesday · estimated from the filing cadence

Profile

Headquarters: BOSTON, MA, United States
Founded: 1989
CEO: Reshma Kewalramani
Sector: Healthcare
Industry: Pharmaceutical Preparations
Website: vrtx.com

Peers

Where this page comes from

Profile · SEC EDGAR, Wikidata

Next results · estimated from the filing cadence (SEC EDGAR)

News · 9 stories clustered from the RSS aggregator